Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Mar 15;370(Pt 3):979–986. doi: 10.1042/BJ20021142

Identification of a non-canonical E-box motif as a regulatory element in the proximal promoter region of the apolipoprotein E gene.

Enrique Salero 1, Cecilio Giménez 1, Francisco Zafra 1
PMCID: PMC1223214  PMID: 12444925

Abstract

We have used the yeast one-hybrid system to identify transcription factors with binding capability to specific sequences in proximal regions of the apolipoprotein E gene ( APOE ) promoter. The sequence between -113 and -80 nt, which contains regulatory elements in various cell types, was used as a bait to screen a human brain cDNA library. Four cDNA clones that encoded portions of the human upstream-stimulatory-factor (USF) transcription factor were isolated. Electrophoretic-mobility-shift assays ('EMSAs') using nuclear extracts from various human cell lines as well as from rat brain and liver revealed the formation of two DNA-protein complexes within the sequence CACCTCGTGAC (region -101/-91 of the APOE promoter) that show similarity to the E-box element. The retarded complexes contained USF1, as deduced from competition and supershift assays. Functional experiments using different APOE promoter-luciferase reporter constructs transiently transfected into U87, HepG2 or HeLa cell lines showed that mutations that precluded the formation of complexes decreased the basal activity of the promoter by about 50%. Overexpression of USF1 in U87 glioblastoma cells led to an increased activity of the promoter that was partially mediated by the atypical E-box. The stimulatory effect of USF1 was cell-type specific, as it was not observed in hepatoma HepG2 cells. Similarly, overexpression of a USF1 dominant-negative mutant decreased the basal activity of the promoter in glioblastoma, but not in hepatoma, cells. These data indicated that USF, and probably other related transcription factors, might be involved in the basal transcriptional machinery of APOE by binding to a non-canonical E-box motif within the proximal promoter.

Full Text

The Full Text of this article is available as a PDF (251.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atchley W. R., Fitch W. M. A natural classification of the basic helix-loop-helix class of transcription factors. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5172–5176. doi: 10.1073/pnas.94.10.5172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berg D. T., Calnek D. S., Grinnell B. W. The human apolipoprotein E gene is negatively regulated in human liver HepG2 cells by the transcription factor BEF-1. J Biol Chem. 1995 Jun 30;270(26):15447–15450. doi: 10.1074/jbc.270.26.15447. [DOI] [PubMed] [Google Scholar]
  3. Boyles J. K., Pitas R. E., Wilson E., Mahley R. W., Taylor J. M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985 Oct;76(4):1501–1513. doi: 10.1172/JCI112130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bresnick E. H., Felsenfeld G. Evidence that the transcription factor USF is a component of the human beta-globin locus control region heteromeric protein complex. J Biol Chem. 1993 Sep 5;268(25):18824–18834. [PubMed] [Google Scholar]
  5. Bullido M. J., Artiga M. J., Recuero M., Sastre I., García M. A., Aldudo J., Lendon C., Han S. W., Morris J. C., Frank A. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet. 1998 Jan;18(1):69–71. doi: 10.1038/ng0198-69. [DOI] [PubMed] [Google Scholar]
  6. Buttini M., Orth M., Bellosta S., Akeefe H., Pitas R. E., Wyss-Coray T., Mucke L., Mahley R. W. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci. 1999 Jun 15;19(12):4867–4880. doi: 10.1523/JNEUROSCI.19-12-04867.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carthew R. W., Chodosh L. A., Sharp P. A. An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. Cell. 1985 Dec;43(2 Pt 1):439–448. doi: 10.1016/0092-8674(85)90174-6. [DOI] [PubMed] [Google Scholar]
  8. Carthew R. W., Chodosh L. A., Sharp P. A. The major late transcription factor binds to and activates the mouse metallothionein I promoter. Genes Dev. 1987 Nov;1(9):973–980. doi: 10.1101/gad.1.9.973. [DOI] [PubMed] [Google Scholar]
  9. Chang D. J., Paik Y. K., Leren T. P., Walker D. W., Howlett G. J., Taylor J. M. Characterization of a human apolipoprotein E gene enhancer element and its associated protein factors. J Biol Chem. 1990 Jun 5;265(16):9496–9504. [PubMed] [Google Scholar]
  10. Chodosh L. A., Carthew R. W., Morgan J. G., Crabtree G. R., Sharp P. A. The adenovirus major late transcription factor activates the rat gamma-fibrinogen promoter. Science. 1987 Oct 30;238(4827):684–688. doi: 10.1126/science.3672119. [DOI] [PubMed] [Google Scholar]
  11. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  12. Du H., Roy A. L., Roeder R. G. Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J. 1993 Feb;12(2):501–511. doi: 10.1002/j.1460-2075.1993.tb05682.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. García M. A., Vázquez J., Giménez C., Valdivieso F., Zafra F. Transcription factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells. J Neurosci. 1996 Dec 1;16(23):7550–7556. doi: 10.1523/JNEUROSCI.16-23-07550.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Grehan S., Tse E., Taylor J. M. Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain. J Neurosci. 2001 Feb 1;21(3):812–822. doi: 10.1523/JNEUROSCI.21-03-00812.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hoffman P. W., Chernak J. M. DNA binding and regulatory effects of transcription factors SP1 and USF at the rat amyloid precursor protein gene promoter. Nucleic Acids Res. 1995 Jun 25;23(12):2229–2235. doi: 10.1093/nar/23.12.2229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ignatius M. J., Gebicke-Härter P. J., Skene J. H., Schilling J. W., Weisgraber K. H., Mahley R. W., Shooter E. M. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci U S A. 1986 Feb;83(4):1125–1129. doi: 10.1073/pnas.83.4.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jo D. W., Leren T. P., Yang Z. Y., Chung Y. H., Taylor J. M., Paik Y. K. Characterization of an upstream regulatory element of the human apolipoprotein E gene, and purification of its binding protein from the human placenta. J Biochem. 1995 Apr;117(4):915–922. doi: 10.1093/oxfordjournals.jbchem.a124796. [DOI] [PubMed] [Google Scholar]
  18. Lambert J-C, Araria-Goumidi L., Myllykangas L., Ellis C., Wang J. C., Bullido M. J., Harris J. M., Artiga M. J., Hernandez D., Kwon J. M. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology. 2002 Jul 9;59(1):59–66. doi: 10.1212/wnl.59.1.59. [DOI] [PubMed] [Google Scholar]
  19. Lambert J. C., Pasquier F., Cottel D., Frigard B., Amouyel P., Chartier-Harlin M. C. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet. 1998 Mar;7(3):533–540. doi: 10.1093/hmg/7.3.533. [DOI] [PubMed] [Google Scholar]
  20. Lanigan T. M., Russo A. F. Binding of upstream stimulatory factor and a cell-specific activator to the calcitonin/calcitonin gene-related peptide enhancer. J Biol Chem. 1997 Jul 18;272(29):18316–18324. doi: 10.1074/jbc.272.29.18316. [DOI] [PubMed] [Google Scholar]
  21. Lefrançois-Martinez A. M., Martinez A., Antoine B., Raymondjean M., Kahn A. Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J Biol Chem. 1995 Feb 10;270(6):2640–2643. doi: 10.1074/jbc.270.6.2640. [DOI] [PubMed] [Google Scholar]
  22. Liaw G. J. Improved protocol for directional multimerization of a DNA fragment. Biotechniques. 1994 Oct;17(4):668–670. [PubMed] [Google Scholar]
  23. Luo X., Sawadogo M. Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1308–1313. doi: 10.1073/pnas.93.3.1308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lüscher B., Larsson L. G. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene. 1999 May 13;18(19):2955–2966. doi: 10.1038/sj.onc.1202750. [DOI] [PubMed] [Google Scholar]
  25. Mahley R. W., Rall S. C., Jr Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507–537. doi: 10.1146/annurev.genom.1.1.507. [DOI] [PubMed] [Google Scholar]
  26. Masliah E., Samuel W., Veinbergs I., Mallory M., Mante M., Saitoh T. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res. 1997 Mar 21;751(2):307–314. doi: 10.1016/s0006-8993(96)01420-5. [DOI] [PubMed] [Google Scholar]
  27. Merrill J. E., Benveniste E. N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 1996 Aug;19(8):331–338. doi: 10.1016/0166-2236(96)10047-3. [DOI] [PubMed] [Google Scholar]
  28. Müller H. W., Gebicke-Härter P. J., Hangen D. H., Shooter E. M. A specific 37,000-dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. Science. 1985 Apr 26;228(4698):499–501. doi: 10.1126/science.3983637. [DOI] [PubMed] [Google Scholar]
  29. Nicoll J. A., Burnett C., Love S., Graham D. I., Ironside J. W., Vinters H. V. High frequency of apolipoprotein E epsilon 2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol. 1996 May;39(5):682–683. doi: 10.1002/ana.410390521. [DOI] [PubMed] [Google Scholar]
  30. Nordeen S. K. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques. 1988 May;6(5):454–458. [PubMed] [Google Scholar]
  31. Outram S. V., Owen M. J. The helix-loop-helix containing transcription factor USF activates the promoter of the CD2 gene. J Biol Chem. 1994 Oct 21;269(42):26525–26530. [PubMed] [Google Scholar]
  32. Page K. J., Hollister R. D., Hyman B. T. Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: an in situ hybridization study. Neuroscience. 1998 Aug;85(4):1161–1171. doi: 10.1016/s0306-4522(97)00661-1. [DOI] [PubMed] [Google Scholar]
  33. Paik Y. K., Chang D. J., Reardon C. A., Walker M. D., Taxman E., Taylor J. M. Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. J Biol Chem. 1988 Sep 15;263(26):13340–13349. [PubMed] [Google Scholar]
  34. Pan L., Black T. A., Shi Q., Jones C. A., Petrovic N., Loudon J., Kane C., Sigmund C. D., Gross K. W. Critical roles of a cyclic AMP responsive element and an E-box in regulation of mouse renin gene expression. J Biol Chem. 2001 Sep 19;276(49):45530–45538. doi: 10.1074/jbc.M103010200. [DOI] [PubMed] [Google Scholar]
  35. Qyang Y., Luo X., Lu T., Ismail P. M., Krylov D., Vinson C., Sawadogo M. Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation. Mol Cell Biol. 1999 Feb;19(2):1508–1517. doi: 10.1128/mcb.19.2.1508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rall S. C., Jr, Weisgraber K. H., Mahley R. W. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem. 1982 Apr 25;257(8):4171–4178. [PubMed] [Google Scholar]
  37. Ribeiro A., Pastier D., Kardassis D., Chambaz J., Cardot P. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J Biol Chem. 1999 Jan 15;274(3):1216–1225. doi: 10.1074/jbc.274.3.1216. [DOI] [PubMed] [Google Scholar]
  38. Salero E., Pérez-Sen R., Aruga J., Giménez C., Zafra F. Transcription factors Zic1 and Zic2 bind and transactivate the apolipoprotein E gene promoter. J Biol Chem. 2000 Oct 18;276(3):1881–1888. doi: 10.1074/jbc.M007008200. [DOI] [PubMed] [Google Scholar]
  39. Sawadogo M., Roeder R. G. Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell. 1985 Nov;43(1):165–175. doi: 10.1016/0092-8674(85)90021-2. [DOI] [PubMed] [Google Scholar]
  40. Sing C. F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 1985 Mar;37(2):268–285. [PMC free article] [PubMed] [Google Scholar]
  41. Sirito M., Walker S., Lin Q., Kozlowski M. T., Klein W. H., Sawadogo M. Members of the USF family of helix-loop-helix proteins bind DNA as homo- as well as heterodimers. Gene Expr. 1992;2(3):231–240. [PMC free article] [PubMed] [Google Scholar]
  42. Slooter A. J., Tang M. X., van Duijn C. M., Stern Y., Ott A., Bell K., Breteler M. M., Van Broeckhoven C., Tatemichi T. K., Tycko B. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA. 1997 Mar 12;277(10):818–821. doi: 10.1001/jama.277.10.818. [DOI] [PubMed] [Google Scholar]
  43. Smith J. D., Melián A., Leff T., Breslow J. L. Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements. J Biol Chem. 1988 Jun 15;263(17):8300–8308. [PubMed] [Google Scholar]
  44. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Teasdale G. M., Nicoll J. A., Murray G., Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet. 1997 Oct 11;350(9084):1069–1071. doi: 10.1016/S0140-6736(97)04318-3. [DOI] [PubMed] [Google Scholar]
  46. Theuns J., Van Broeckhoven C. Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility. Hum Mol Genet. 2000 Oct;9(16):2383–2394. doi: 10.1093/hmg/9.16.2383. [DOI] [PubMed] [Google Scholar]
  47. Wang D., Sul H. S. Upstream stimulatory factor binding to the E-box at -65 is required for insulin regulation of the fatty acid synthase promoter. J Biol Chem. 1997 Oct 17;272(42):26367–26374. doi: 10.1074/jbc.272.42.26367. [DOI] [PubMed] [Google Scholar]
  48. Xu P. T., Gilbert J. R., Qiu H. L., Rothrock-Christian T., Settles D. L., Roses A. D., Schmechel D. E. Regionally specific neuronal expression of human APOE gene in transgenic mice. Neurosci Lett. 1998 Apr 24;246(2):65–68. doi: 10.1016/s0304-3940(98)00247-x. [DOI] [PubMed] [Google Scholar]
  49. Zannis V. I., Breslow J. L. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry. 1981 Feb 17;20(4):1033–1041. doi: 10.1021/bi00507a059. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES